Prevalence and mechanisms of macrolide resistance in <i>Streptococcus pyogenes</i> in Santiago, Chile
dc.contributor.author | Palavecino, EL | |
dc.contributor.author | Riedel, I | |
dc.contributor.author | Berrios, X | |
dc.contributor.author | Bajaksouzian, S | |
dc.contributor.author | Johnson, D | |
dc.contributor.author | Kaplan, E | |
dc.contributor.author | Jacobs, MR | |
dc.date.accessioned | 2025-01-21T01:31:01Z | |
dc.date.available | 2025-01-21T01:31:01Z | |
dc.date.issued | 2001 | |
dc.description.abstract | Thirty-two macrolide-resistant Streptococcus pyogenes isolates were found among 594 clinical isolates collected from 1990 to 1998 in Santiago, Chile, for an overall prevalence of 7.2%. Among the 32 resistant isolates, 28 (87.5%) presented the M phenotype and 4 (12.5%) presented the MLSB phenotype. Serotyping and pulsed-field gel electrophoresis analysis showed genetic diversity among the resistant isolates. | |
dc.fuente.origen | WOS | |
dc.identifier.issn | 0066-4804 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/96960 | |
dc.identifier.wosid | WOS:000165952500057 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 341 | |
dc.pagina.inicio | 339 | |
dc.revista | Antimicrobial agents and chemotherapy | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Prevalence and mechanisms of macrolide resistance in <i>Streptococcus pyogenes</i> in Santiago, Chile | |
dc.type | artículo | |
dc.volumen | 45 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |